Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
MDG1:FRA
MediGene AG
€0.022
+7.77%
(+0.0016) 1D
Apr 23, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MDG1...
Open
€0.02
High
€0.02
Low
€0.02
Mkt. cap
340.41K
Avg. vol.
2.59K
Volume
1.31K
52-wk high
€0.22
52-wk low
€0.01
Shares outstanding
24.56M
No. of employees
87
News stories
From sources across the web
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
About MediGene AG
CEODolores J. Schendel
Employees87
Founded1994
HeadquartersPlanegg, Bavaria, Germany
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
-
-
2.24M
1.46M
Cost of goods sold
-
-
386.50K
333.00K
Cost of revenue
-
-
386.50K
333.00K
Research and development expenses
-
-
3.14M
3.13M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
2.03M
2.09M
Operating expense
-
-
5.17M
5.22M
Total operating expenses
-
-
5.56M
5.55M
Operating income
-
-
-3.32M
-4.10M
Other non operating income
-
-
-5.00K
-6.00K
EBT including unusual items
-
-
-3.36M
-4.08M
EBT excluding unusual items
-
-
-3.36M
-4.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-3.00K
-2.00K
Net income
-
-
-3.36M
-4.08M
Net profit margin
-
-
-150.27%
-280.10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
55.50K
110.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
55.50K
110.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-2.97M
-3.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more